MHS1
Mayer′s Hematoxylin Solution
Sign In to View Organizational & Contract Pricing.
Select a Size
Change View
About This Item
form
solution
Quality Level
shelf life
Expiry date on the label.
IVD
for in vitro diagnostic use
concentration
1 g/L
pH
2.4 (25 °C)
application(s)
hematology
histology
storage temp.
room temp
SMILES string
Oc1cc2C[C@@]3(O)COc4c(O)c(O)ccc4[C@H]3c2cc1O
InChI
1S/C16H14O6/c17-10-2-1-8-13-9-4-12(19)11(18)3-7(9)5-16(13,21)6-22-15(8)14(10)20/h1-4,13,17-21H,5-6H2/t13-,16+/m0/s1
InChI key
WZUVPPKBWHMQCE-XJKSGUPXSA-N
General description
Used as a counterstain for procedures such as immunohistochemistry or laser microdissection.
Application
General purpose nuclear stain, progressive type. Used with hematoxylin and eosin staining.
Other Notes
1 g/L certified hematoxylin
Still not finding the right product?
Explore all of our products under Mayer′s Hematoxylin Solution
Storage Class
12 - Non Combustible Liquids
flash_point_f
Not applicable
flash_point_c
Not applicable
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Protocols
Use this protocol to for the entire immunohistochemistry (IHC) procedure through staining and visualization of specific antigens in paraffin-embedded tissue sections.
Michael Taylor Hensley et al.
Journal of cellular and molecular medicine, 21(8), 1503-1512 (2017-03-16)
Cardiosphere-derived cells (CDCs) have been shown to reduce scar size and increase viable myocardium in human patients with mild/moderate myocardial infarction. Studies in rodent models suggest that CDC therapy may confer therapeutic benefits in patients with non-ischaemic dilated cardiomyopathy (DCM).
Shih-Jie Jhuo et al.
International journal of molecular sciences, 22(11) (2021-07-03)
Empagliflozin (EMPA) is a sodium-glucose transporter 2 (SGLT2) inhibitor that functions as a new-generation glucose-lowering agent and has been proven to be beneficial for patients with cardiovascular diseases. However, the possible benefits and mechanisms of its antiarrhythmic effects in cardiac
Gretchen M Alicea et al.
Cancer discovery, 10(9), 1282-1295 (2020-06-06)
Older patients with melanoma (>50 years old) have poorer prognoses and response rates to targeted therapy compared with young patients (<50 years old), which can be driven, in part, by the aged microenvironment. Here, we show that aged dermal fibroblasts
Global Trade Item Number
| SKU | GTIN |
|---|---|
| MHS1-100ML | 04061834066453 |